IUPAC Name: | 4-chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine |
Description: | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. |
Molecular Weight: | 155.58 |
Molecular Formula: | C6H6ClN3 |
Canonical SMILES: | C1CNC2=C1C(=NC=N2)Cl |
InChI: | InChI=1S/C6H6ClN3/c7-5-4-1-2-8-6(4)10-3-9-5/h3H,1-2H2,(H,8,9,10) |
InChI Key: | LJXVPXRXXVHTBP-UHFFFAOYSA-N |
Boiling Point: | 252.4±50.0 °C at 760mmHg |
Melting Point: | 164-166°C |
Purity: | 97% |
Density: | 1.63±0.1 g/cm3 |
Solubility: | Soluble in DMSO (Slightly), Methanol (Slightly) |
Appearance: | Pale Tan Solid |
Storage: | Store at -20°C |
MDL: | MFCD11518925 |
LogP: | 1.61130 |
Customer Support
If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?
Customer Centered
Related Functional Groups
Halides
1-{4-[3-(Trifluoromethyl)-1H-pyrazol-1-yl]phenyl}methanamine hydrochloride
Customers Also Viewed
Copyright © 2025 BOC Sciences. All rights reserved.
Our Products